Japan’s Switch Committee Resists Full Reform
Executive Summary
Japan’s Rx-to-OTC Switching Evaluation Committee has accepted most of the reforms mandated by the country’s government as part of its attempt to reform the national medicines reclassification system. However, it still has more of a role than industry would perhaps like.
You may also be interested in...
Seven-Year Legal Challenge To Japan’s OTC Online Sales Ban Fails
Japan’s Supreme Court has delivered a final ruling on a seven year dispute over online sales of non-prescription medicines. The Court has rejected a complaint against the ban on distant selling of OTCs in the most-strictly-regulated category, that of recently switched drugs. Meanwhile, the Japanese government is extending the country’s Self-Medication Tax Deduction System for another five years.
Japan Embarks On Rx-To-OTC Switch Revolution
The Japanese government has approved a raft of measures aimed at expanding the country's consumer health market, including reforms to an Evaluation Committee that has not lived up to its promise of expediting Rx-to-OTC switches.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.